StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Gone for 2 weeks

<< Previous

Bullboard Posts

Next >>

Comment by IainCaimbeulon Apr 30, 2021 10:39am

86 Views

Post# 33100819

RE:RE:Gone for 2 weeks

Liked2think: This is a side play for me, I bought 80% pre-RS so I don't feel the searing pain you do.

I am extremely annoyed at Stage for the mickey mouse rollout of aristotle and the CC.

The state of the current stock price is friendly fire, entirely self-inflicted by Stage management.

I would like to see one simple line on a financial sheet that shows:
colonsentry revenues: $$$$$.$$
aristotle revenues: $$$$$.$$

But no, heaven forbid some real dsiclosure.

<< Previous

Bullboard Posts

Next >>

Mid-year update: Charting GameSquare’s sharp business growth